HFS
TSHA icon

Hughes Financial Services’s Taysha Gene Therapies TSHA Stock Holding History

Hughes Financial Services’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41 Buy
+6
New +$36 ﹤0.01% 1640
2026
Q1 		– Sell
-4
Closed -$22 – 1801
2025
Q4 		$22 Buy
+4
New +$19 ﹤0.01% 1218

Other funds holding TSHA

AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RRA
Red Reef Advisors Boca Raton, Florida $108M AUM
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Hughes Financial Services's TSHA Position: Q2 2026 in Review

Hughes Financial Services opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 6 shares worth $41. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings. This is a return to the name: Hughes Financial Services previously reported a position in TSHA as recently as Q4 2025.

Hughes Financial Services first reported a position in TSHA in Q4 2025 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Hughes Financial Services held 6 shares of Taysha Gene Therapies worth $41 as of Q2 2026.
  • Taysha Gene Therapies was a new Hughes Financial Services position in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1640 holding.
  • Hughes Financial Services first reported a position in Taysha Gene Therapies in Q4 2025 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.